# Pre-Surgical Ocular Surface Treatment With Intracanalicular Dexamethasone Insert And Effect On Intraocular Lens Measurement Accuracy

> **NCT04530864** · PHASE4 · UNKNOWN · sponsor: **Prism Vision Group** · enrollment: 35 (estimated)

## Conditions studied

- Dry Eye Disease
- Cataract Surgery
- Ocular Surface Disease

## Interventions

- **DRUG:** Dextenza 0.4Mg Ophthalmic Insert

## Key facts

- **NCT ID:** NCT04530864
- **Lead sponsor:** Prism Vision Group
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01
- **Primary completion:** 2021-01
- **Final completion:** 2021-07
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2020-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04530864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04530864, "Pre-Surgical Ocular Surface Treatment With Intracanalicular Dexamethasone Insert And Effect On Intraocular Lens Measurement Accuracy". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04530864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*